Some patients with severe or moderate COVID-19 show a deficient expression of IFN-γ in CD4+ T lymphocytes, CD8+ T lymphocytes, and NK cells; however, lower levels of IFN-γ expression by CD4+ T lymphocytes are found in those with severe rather than moderate COVID-19 [34]. This evidence concerns the gene IFNG and COVID-19.